Labcorp
Search results
Labcorp's global research, development and testing organization provides drug and medical device development services. We serve pharmaceutical and biotechnology companies.
Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.
Through our unparalleled diagnostics and drug development laboratory capabilities, our 60,000+ employees combine cutting-edge innovation, science and technology to solve some of today’s biggest health challenges, accelerate life-changing healthcare breakthroughs and impact lives around the world. About Us. Embrace possibilities, change lives.
Together with our clients, we support the development of innovative, life-changing treatments. We are a leading contract research organization (CRO) that provides drug development research and testing services to the drug, medical device, crop protection and chemical industries.
At Labcorp, we rely on the participation of people like you to make this happen. Visit our Global Trial Source site to find clinical trials. Labcorp Drug Development is focused on moving health forward for all, and clinical trials are essential to our mission.
From central laboratory services to companion diagnostics, Labcorp Drug Development supports your assay and biomarker needs in clinical testing.
This transformation will enable Labcorp’s drug development business, Covance, a global leader in decentralized clinical trials (DCTs), to quickly and efficiently connect patients to clinical trials, which will allow for better access to potential drugs, vaccines, and medical devices.
